Cwm, LLC Humacyte, Inc. Transaction History

Cwm, LLC

$33.3 Billion
Q3 2025

A detailed history of Cwm, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Cwm, LLC holds 15,062 shares of HUMA stock, worth $26,057. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,062

Previous 43,531 65.4%

Holding current value

$26,057

Previous $91,000 71.43%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	SELL	$1.41 - $2.73 $40,141 - $77,720	-28,469 Reduced 65.4%	15,062 $26,000
Q2 2025 Jul 25, 2025	BUY	$1.15 - $2.77 $49,893 - $120,179	43,386 Added 29921.38%	43,531 $91,000
Q1 2025 May 01, 2025	SELL	$1.71 - $5.18 $1,061 - $3,216	-621 Reduced 81.07%	145 $0
Q4 2024 Feb 04, 2025	SELL	$3.46 - $5.81 $7,217 - $12,119	-2,086 Reduced 73.14%	766 $4,000
Q3 2024 Oct 08, 2024	BUY	$5.11 - $9.46 $403 - $747	79 Added 2.85%	2,852 $16,000
Q2 2024 Jul 09, 2024	BUY	$2.87 - $9.1 $7,958 - $25,234	2,773 New	2,773 $13,000
Q4 2023 Feb 01, 2024	BUY	$1.99 - $3.12 $21 - $34	11 New	11 $0

Others Institutions Holding HUMA

# of Institutions

166

Shares Held

54.4M

Call Options Held

1.1M

Put Options Held

808K

View Full List

About Humacyte, Inc.

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $178M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

More about HUMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account